| Metric | შპს Linema Pharm | შპს თეგა ფარმა | შპს ირისე |
|---|---|---|---|
| Growth | |||
| Revenue | ₾3.9m₾2.1m | ₾3.9m₾5.3m | ₾10.0m₾3.6m |
| Revenue growth | 88.1% | -26.7% | 180.2% |
| Profitability | |||
| EBITDA | ₾1.6m₾602k | ₾67k₾235k | ₾1.6m₾658k |
| EBITDA margin | 40.5%28.9% | 1.7%4.4% | 15.6%18.4% |
| Net profit | ₾1.5m₾581k | ₾16k₾140k | ₾1.5m₾551k |
| Net margin | 38.9%27.9% | 0.4%2.6% | 15.0%15.4% |
| Balance sheet | |||
| Total assets | ₾6.3m₾4.9m | ₾597k₾1.4m | ₾3.1m₾1.2m |
| Total equity | ₾5.6m₾4.3m | ₾550k₾628k | ₾2.2m₾989k |
| ROE | 27.1%13.6% | 2.9%22.3% | 67.9%55.7% |